APO Research
Talk to an analyst

APO RESEARCH · REPORT

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Research Report 2026

29 December 2025126 pages

Choose your research edition.

Industry ResearchPIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine include Bioveta, Boehringer Ingelheim, CAVAC, Ceva Santé Animale, HIPRA, Jinyu Bio-Technology, Sinopharm Animal Health Co., Ltd, Zoetis and Harbin Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Company

Bioveta

Boehringer Ingelheim

CAVAC

Ceva Santé Animale

HIPRA

Jinyu Bio-Technology

Sinopharm Animal Health Co., Ltd

Zoetis

Harbin Pharmaceutical Group

Merck

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type

CH-1R Strain

PC Strain

Others

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application

Gilts

Sows

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Product Type & Application Table 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Bioveta Company Information Table 19. Bioveta Business Overview Table 20. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 22. Bioveta Recent Developments Table 23. Boehringer Ingelheim Company Information Table 24. Boehringer Ingelheim Business Overview Table 25. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 27. Boehringer Ingelheim Recent Developments Table 28. CAVAC Company Information Table 29. CAVAC Business Overview Table 30. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 32. CAVAC Recent Developments Table 33. Ceva Santé Animale Company Information Table 34. Ceva Santé Animale Business Overview Table 35. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 37. Ceva Santé Animale Recent Developments Table 38. HIPRA Company Information Table 39. HIPRA Business Overview Table 40. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 42. HIPRA Recent Developments Table 43. Jinyu Bio-Technology Company Information Table 44. Jinyu Bio-Technology Business Overview Table 45. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 47. Jinyu Bio-Technology Recent Developments Table 48. Sinopharm Animal Health Co., Ltd Company Information Table 49. Sinopharm Animal Health Co., Ltd Business Overview Table 50. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 52. Sinopharm Animal Health Co., Ltd Recent Developments Table 53. Zoetis Company Information Table 54. Zoetis Business Overview Table 55. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 57. Zoetis Recent Developments Table 58. Harbin Pharmaceutical Group Company Information Table 59. Harbin Pharmaceutical Group Business Overview Table 60. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 62. Harbin Pharmaceutical Group Recent Developments Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 67. Merck Recent Developments Table 68. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026) & (K Units) Table 70. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2021-2026) Table 71. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2027-2032) & (K Units) Table 72. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2027-2032) Table 73. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 74. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2021-2026) Table 75. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 76. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2027-2032) Table 77. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 79. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 80. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 81. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 84. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 85. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 89. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 90. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 92. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 94. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 95. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 96. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 99. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 100. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 102. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 103. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (K Units) Table 104. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2026) Table 105. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2027-2032) Table 106. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 107. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 108. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2026) Table 109. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2027-2032) Table 110. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2026) & (US$/Unit) Table 111. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2027-2032) & (US$/Unit) Table 112. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 113. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (K Units) Table 114. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2026) Table 115. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2027-2032) Table 116. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 117. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 118. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2026) Table 119. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2027-2032) Table 120. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2026) & (US$/Unit) Table 121. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2027-2032) & (US$/Unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List Table 125. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers List Table 126. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends Table 127. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers Table 128. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Image Figure 5. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2021-2032) & (K Units) Figure 8. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (US$/Unit) & (2021-2032) Figure 9. CH-1R Strain Product Image Figure 10. PC Strain Product Image Figure 11. Others Product Image Figure 12. Gilts Product Image Figure 13. Sows Product Image Figure 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region in 2025 Figure 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region in 2025 Figure 21. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country in 2025 Figure 22. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 23. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2021-2032) Figure 24. United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country in 2025 Figure 27. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 28. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2021-2032) Figure 29. Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Netherlands PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country in 2025 Figure 35. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 36. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2021-2032) Figure 37. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. China Taiwan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country in 2025 Figure 46. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 47. South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2021-2032) Figure 48. Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country in 2025 Figure 52. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 53. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2021-2032) Figure 54. Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. UAE PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2032) Figure 58. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2032) Figure 59. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Type (2021-2032) Figure 60. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2032) Figure 61. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2032) Figure 62. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Application (2021-2032) Figure 63. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Figure 64. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • CH-1R Strain
  • PC Strain
  • Others
Applications
  • Gilts
  • Sows
Companies covered
  • Bioveta
  • Boehringer Ingelheim
  • CAVAC
  • Ceva Santé Animale
  • HIPRA
  • Jinyu Bio-Technology
  • Sinopharm Animal Health Co., Ltd
  • Zoetis
  • Harbin Pharmaceutical Group
  • Merck

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (2021-2032)
  4. 2.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2021-2032)
  5. 2.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Average Price (2021-2032)
  6. 2.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 CH-1R Strain
  9. 2.3.3 PC Strain
  10. 2.3.4 Others
  11. 2.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Gilts
  14. 2.4.3 Sows
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Established Date
  9. 3.9 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Bioveta
  2. 4.1.1 Bioveta Company Information
  3. 4.1.2 Bioveta Business Overview
  4. 4.1.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  6. 4.1.5 Bioveta Recent Developments
  7. 4.2 Boehringer Ingelheim
  8. 4.2.1 Boehringer Ingelheim Company Information
  9. 4.2.2 Boehringer Ingelheim Business Overview
  10. 4.2.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  12. 4.2.5 Boehringer Ingelheim Recent Developments
  13. 4.3 CAVAC
  14. 4.3.1 CAVAC Company Information
  15. 4.3.2 CAVAC Business Overview
  16. 4.3.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  18. 4.3.5 CAVAC Recent Developments
  19. 4.4 Ceva Santé Animale
  20. 4.4.1 Ceva Santé Animale Company Information
  21. 4.4.2 Ceva Santé Animale Business Overview
  22. 4.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  24. 4.4.5 Ceva Santé Animale Recent Developments
  25. 4.5 HIPRA
  26. 4.5.1 HIPRA Company Information
  27. 4.5.2 HIPRA Business Overview
  28. 4.5.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  30. 4.5.5 HIPRA Recent Developments
  31. 4.6 Jinyu Bio-Technology
  32. 4.6.1 Jinyu Bio-Technology Company Information
  33. 4.6.2 Jinyu Bio-Technology Business Overview
  34. 4.6.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  36. 4.6.5 Jinyu Bio-Technology Recent Developments
  37. 4.7 Sinopharm Animal Health Co., Ltd
  38. 4.7.1 Sinopharm Animal Health Co., Ltd Company Information
  39. 4.7.2 Sinopharm Animal Health Co., Ltd Business Overview
  40. 4.7.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  42. 4.7.5 Sinopharm Animal Health Co., Ltd Recent Developments
  43. 4.8 Zoetis
  44. 4.8.1 Zoetis Company Information
  45. 4.8.2 Zoetis Business Overview
  46. 4.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  48. 4.8.5 Zoetis Recent Developments
  49. 4.9 Harbin Pharmaceutical Group
  50. 4.9.1 Harbin Pharmaceutical Group Company Information
  51. 4.9.2 Harbin Pharmaceutical Group Business Overview
  52. 4.9.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  54. 4.9.5 Harbin Pharmaceutical Group Recent Developments
  55. 4.10 Merck
  56. 4.10.1 Merck Company Information
  57. 4.10.2 Merck Business Overview
  58. 4.10.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  60. 4.10.5 Merck Recent Developments
5 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Scenario by Region
  1. 5.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2027-2032
  5. 5.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
  15. 5.5.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  17. 5.5.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
  35. 5.7.1 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  37. 5.7.3 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Analysis
  2. 8.1.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process
  5. 8.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
  8. 8.2.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers
9 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Analyzing Market Dynamics
  1. 9.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
  2. 9.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers
  3. 9.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges
  4. 9.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst